An update on donor-derived disease transmission in organ transplantation

American Journal of Transplantation

Volumn 11, Issue 6, 2011, Pages 1123-1130

  Ison, M G ^a   Nalesnik, M A ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

donor screening; Donor derived; infection; malignancy; patient safety; transplantation

Indexed keywords

ACINETOBACTER INFECTION; ADENOVIRUS INFECTION; ASPERGILLOSIS; BABESIOSIS; BACTERIAL MENINGITIS; BRUCELLOSIS; CANDIDIASIS; CARCINOMA; CHAGAS DISEASE; COCCIDIOIDOMYCOSIS; CRYPTOCOCCOSIS; DISEASE TRANSMISSION; EHRLICHIOSIS; ENTEROCOCCAL INFECTION; ERYTHEMA INFECTIOSUM; ESCHERICHIA COLI INFECTION; FOLLOW UP; GLIOBLASTOMA; GRAFT RECIPIENT; HEPATITIS B; HEPATITIS C; HERPES SIMPLEX; HISTOPLASMOSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN T CELL LEUKEMIA VIRUS INFECTION; INFLUENZA; KIDNEY CARCINOMA; KLEBSIELLA INFECTION; LEGIONNAIRE DISEASE; LISTERIOSIS; LIVER CANCER; LUNG CANCER; LYME DISEASE; LYMPHOMA; MELANOMA; METASTASIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MORBIDITY; MORTALITY; NOCARDIOSIS; ORGAN DONOR; ORGAN TRANSPLANTATION; OVARY CARCINOMA; PANCREAS CANCER; PARAINFLUENZA VIRUS INFECTION; PARASITEMIA; PRIMARY AMEBIC MENINGOENCEPHALITIS; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PSEUDOMONAS INFECTION; RABIES; REVIEW; ROCKY MOUNTAIN SPOTTED FEVER; SCHISTOSOMIASIS; SERRATIA INFECTION; STEROID THERAPY; STREPTOCOCCUS INFECTION; STRONGYLOIDIASIS; SYPHILIS; THYROID CARCINOMA; TUBERCULOSIS; WEST NILE FEVER; ZYGOMYCOSIS;

DISEASE TRANSMISSION, INFECTIOUS; HUMANS; NEOPLASMS; ORGAN TRANSPLANTATION; TISSUE DONORS; UNITED STATES;

EID: 79958806134     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2011.03493.x     Document Type: Review

References (35)

1. Fischer SA, Avery RK, Practice tAIDCo. Screening of donor and recipient prior to solid organ transplantation. Am J Transplant 2009; 9 (Suppl 4): s7-s18.
2. Levitsky J, Doucette K, Practice tAIDCo. Viral hepatitis in solid organ transplant recipients. Am J Transplant 2009; 9 (Suppl 4): s116-s130.
3. Ison MG, Hager J, Blumberg E, et al,. Donor-derived disease transmission events in the united states: Data reviewed by the OPTN/UNOS disease transmission advisory committee. Am J Transplant 2009; 9: 1929-1935.
4. Fischer SA, Graham MB, Kuehnert MJ, et al,. Transmission of lymphocytic choriomeningitis virus by organ transplantation. N Engl J Med 2006; 354: 2235-2249. (Pubitemid 43788138)
5. Iwamoto M, Jernigan DB, Guasch A, et al,. Transmission of West Nile virus from an organ donor to four transplant recipients. N Engl J Med 2003; 348: 2196-2203. (Pubitemid 36618130)
6. Lumbreras C, Sanz F, Gonzalez A, et al,. Clinical significance of donor-unrecognized bacteremia in the outcome of solid-organ transplant recipients. Clin Infect Dis 2001; 33: 722-726. (Pubitemid 32762948)
7. Palacios G, Druce J, Du L, et al,. A new arenavirus in a cluster of fatal transplant-associated diseases. N Engl J Med 2008; 358: 991-998. (Pubitemid 351347098)
8. Srinivasan A, Burton EC, Kuehnert MJ, et al,. Transmission of Rabies virus from an organ donor to four transplant recipients. N Engl J Med 2005; 352: 1103-1111. (Pubitemid 40365351)
9. Ison MG, Friedewald JJ,. Transmission of human immunodeficiency virus and hepatitis C virus through liver transplantation. Liver Transpl 2009; 15: 561; author reply 562.
10. Chagas disease after organ transplantation-United States, 2001. MMWR Morb Mortal Wkly Rep 2002; 51: 210-212.
11. Chagas disease after organ transplantation-Los Angeles, California, 2006. MMWR Morb Mortal Wkly Rep 2006; 55: 798-800.
12. Transplantation-transmitted tuberculosis-Oklahoma and Texas, 2007. MMWR Morb Mortal Wkly Rep 2008; 57: 333-336.
13. The National Organ Transplant Act. In. 42 U.S.C. 273 et seq. (1987).
14. The OPTN Final Rule. In. 42 CFR, part 121 et seq.
15. Guidelines for preventing transmission of human immunodeficiency virus through transplantation of human tissue and organs. MMWR Morb Mortal Wkly Rep 1994; 43 (RR-8): 1-17.
16. OPTN Policy 2. Available at:. Accessed on February 6, 2011.
17. OPTN Policy 4. Available at:. Accessed on February 6, 2011.
18. Kaye S, Baddon A, Jones M, Armitage WJ, Fehily D, Warwick RM,. A UK scheme for reporting serious adverse events and reactions associated with ocular tissue transplantation. Cell Tissue Bank 2010; 11: 39-46.
19. European Directorate for the Quality of Medicines and Healthcare. Guide to safety and quality assurance for the transplantation of organs tissues and cells, 3rd Ed. Strasbourg, France: Council of Europe Publishing, 2009.
20. Buell JF, Hanaway MJ, Thomas M, et al,. Donor kidneys with small renal cell cancers: Can they be transplanted Transplant Proc 2005; 37: 581-582. (Pubitemid 40590632)
21. Nicol DL, Preston JM, Wall DR, et al,. Kidneys from patients with small renal tumours: A novel source of kidneys for transplantation. BJU Int 2008; 102: 188-192; discussion 192-193. (Pubitemid 351852587)
22. Yin M, Bastacky S, Chandran U, Becich MJ, Dhir R,. Prevalence of incidental prostate cancer in the general population: A study of healthy organ donors. J Urol 2008; 179 (3): 892-895; discussion 895.
23. Ison MG,. The epidemiology and prevention of donor-derived infections. Adv Chronic Kidney Dis 2009; 16: 234-241.
24. Humar A, Morris M, Blumberg E, et al,. Nucleic acid testing (NAT) of organ donors: Is the 'Best' test the right test? A consensus conference report. Am J Transplant 2010; 10: 889-899.
25. Proia L, Miller R,. Endemic fungal infections in solid organ transplant recipients. Am J Transplant 2009; 9 (Suppl 4): S199-S207.
26. Singh N, Forrest G,. Cryptococcosis in solid organ transplant recipients. Am J Transplant 2009; 9 (Suppl 4): S192-S198.
27. Kotton CN, Lattes R,. Parasitic infections in solid organ transplant recipients. Am J Transplant 2009; 9 (Suppl 4): S234-S251.
28. Grossi PA, Fishman JA,. Donor-derived infections in solid organ transplant recipients. Am J Transplant 2009; 9 (Suppl 4): S19-S26.
29. Kucirka LM, Wolfe J, Sarathy H, Govindan P, Montgomery R, Segev DL,. The risk of window period HIV and HCV infection in high risk donors: A meta-analysis. San Diego, California: American transplant congress, 2010: Abstract LB 22.
30. West Nile virus infections in organ transplant recipients-New York and Pennsylvania, August-September, 2005. MMWR Morb Mortal Wkly Rep 2005; 54: 1021-1023.
31. Ison MG, Stosor V,. Transplantation of high-risk donor organs: A survey of US solid organ transplant center practices as reported by transplant infectious diseases physicians. Clin Transplant 2009; 23: 866-873.
32. Glynn SA, Kleinman SH, Schreiber GB, et al,. Trends in incidence and prevalence of major transfusion-transmissible viral infections in US blood donors, 1991 to 1996. Retrovirus epidemiology donor study (REDS). JAMA 2000; 284: 229-235. (Pubitemid 30460868)
33. Murphy EL, Bryzman SM, Glynn SA, et al,. Risk factors for hepatitis C virus infection in United States blood donors. NHLBI retrovirus epidemiology donor study (REDS). Hepatology 2000; 31: 756-762. (Pubitemid 30118647)
34. Fishman JA, Strong DM, Kuehnert MJ,. Organ and tissue safety workshop 2007: Advances and challenges. Cell Tissue Bank 2008; 10: 271-280.
35. Tugwell BD, Patel PR, Williams IT, et al,. Transmission of hepatitis C virus to several organ and tissue recipients from an antibody-negative donor. Ann Intern Med 2005; 143: 648-654.